The stereoselective effects of bucolome on the pharmacokinetics and pharmacodynamics of racemic warfarin

Journal of Clinical Pharmacology

Volumn 41, Issue 4, 2001, Pages 459-464

  Matsumoto, K ^a   Ishida, S ^a   Ueno, K ^a   Hashimoto, H ^a   Takada, M ^a   Tanaka, K ^a   Kamakura, S ^a   Miyatake, K ^a   Shibakawa, M ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUCOLOME; CYTOCHROME P450 2C9; WARFARIN;

ADULT; AGED; ANALGESIA; ANTICOAGULATION; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG CROSS REACTIVITY; ENANTIOMER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; RACEMIC MIXTURE; RANDOMIZED CONTROLLED TRIAL; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; BARBITURATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HEART DISEASES; HUMANS; JAPAN; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; STEREOISOMERISM; TIME FACTORS; WARFARIN;

EID: 0035066355     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700122010186     Document Type: Article

References (18)

1. Studies on the optical enantiomorphs of warfarin in man
2. Stereochemical aspects of its metabolism and interaction with phenylbutazone
3. Warfarin: Metabolism and mode of action
4. Human P450 metabolism of warfarin
5. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: A role for P4502C9 in the etiology of (S)-warfarin-drug interactions
6. The mechanism of the interaction between amiodarone and warfarin in humans
7. Interaction of amiodarone with racemic warfarin and its separated enantiomorphs in humans
8. Mechanism of warfarin potentiation by amiodarone: Dose- and concentration-dependent inhibition of warfarin elimination
9. Interaction between warfarin and propafenone in healthy volunteer subjects
10. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans
11. Clinically important drug interactions with anticoagulants
12. Inhibition of S-warfarin metabolism by nonsteroidal antiinflammatory drugs in human liver microsomes in vitro
13. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man
14. Stereochemical aspects of warfarin drug interactions: Use of a combined pharmacokinetic-pharmacodynamic model
15. Metabolic fate and the pharmacokinetics of 5-n-butyl-1-cyclohexyl-2, 4, 6-trioxoperhydropyrimidine (BCP) in man
16. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: Application of in vitro approaches to predicting in vivo reduction of (S)-warfarin clearance
17. Prediction of creatinine clearance from serum creatinine
18. Stereoselective interaction of sulfinpyrazone with racemic warfarin and its separated enantiomorphs in man